Id: CBI_2412 | Pages: 306 | Format : PDF | Published : | Author : Amit Sati | Category : Healthcare
The ascites market size is growing with a CAGR of 4.0% during the forecast period (2025-2032), and the market is projected to be valued at USD 2,668.24 Million by 2032 from USD 1,954.44 Million in 2024. Additionally, the market value for 2025 attributes to USD 2,025.94 Million.
Ascites is the medical condition that refers to the abnormal accumulation of fluid in the peritoneal cavity. It is commonly caused by liver cirrhosis, liver cancer, infections or heart diseases. The symptom in this condition includes abdominal swelling, discomfort, difficulty breathing, and weight gain. There are two types of this condition- transudative and exudative. The diagnostic methods include computed tomography (CT) scan, blood test, laparoscopy, and others. There are different treatment options for ascitic patients such as diuretics, paracentesis, surgery, and others. Ascites is diagnosed and treated by hospitals, ambulatory surgical centers, specialty clinics and others. Further, advancement in minimally invasive treatment options is enhancing the management of ascetic fluid among the patients thereby driving the market demand.
Chronic Hepatitis B is a long-term infection with the Hepatitis B virus disease that persists for deterioration of liver functions for more than six months leading to inflammation and impaired liver function over time. It causes increased pressure in the portal vein which leads to fluid leakage in the abdomen causing ascites. The cases of chronic hepatitis B are growing due to high transmission rates, lack of early symptoms, and rising population, further driving the market.
Thus, the high global prevalence of chronic hepatitis B is leading to ascites market demand.
Technological advancements of devices in management of ascites are major driver in the market. It includes a peritoneal catheter system and large volume paracentesis. Peritoneal dialysis catheters continuously drainage the ascetic fluid while large volume paracentesis is useful for severe and resistant ascites. Moreover, companies are developing implantable medical devices for the management of this condition.
Hence, technological advancements in treatment are leading to ascites market expansion.
Rules and regulations are significantly restraining the market due to stringent requirements for the approval of diagnostics tools and new drug medications. There are lengthy and complex approval processes for new medications and implantable medical devices. This involves multiple stages, including preclinical trials, testing, and biocompatibility evaluations, which are time-intensive and costly. It delays the introduction of innovative treatments, limiting treatment options for ascitic patients. Regulatory agencies such as United States Food and Drug Administration, European Medicines Agency, and others require extensive clinical trials and data before granting approval to drug medications and medical devices. Thus, rules and regulations are constraining market growth due to regulatory standards and complex approval processes for new medications.
Malignant ascites is an abnormal buildup of fluids in the abdominal cavity due to cancer spreads. It has limited treatment options such as paracentesis, diuretics, and shunt placement. The malignant ascites cases are growing due to rising cancer incidence and lack of early symptoms. Due to this, companies are expanding treatment options for this condition.
Hence, expanding treatment options for malignant ascites is expected to create ascites market opportunities
Based on ascites type, the market is categorized as transudative and exudative.
Trends in Ascites Type:
The transudative segment accounted for the largest market share in the year 2024.
The exudative segment is expected to grow at the fastest CAGR over the forecast period.
Based on type, the market is categorized into diagnosis and treatment.
Trends in Type:
The diagnosis segment accounted for the largest market share in the year 2024.
The treatment segment is expected to grow at the fastest CAGR over the forecast period.
Based on end-user, the market is categorized into hospitals, ambulatory surgical centers, specialty clinics and others.
Trends in End-User:
The hospitals segment accounted for the largest market share of 54.19% in the year 2024.
The ambulatory surgical centers segment is expected to grow at the fastest CAGR over the forecast period.
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2024, North America accounted for the highest market share at 40.98% and was valued at USD 800.90 Million and is expected to reach USD 1,032.15 Million in 2032. In North America, United States accounted for the highest ascites market share of 72.02% during the base year of 2024. As per market analysis, North America holds a dominant position in the market due to growing cases of liver cancer. Countries such as United States, Canada, and Mexico are major contributors in the market due to growing cases of liver cancer.
Thus, North America is leading in the market due to growing cases of liver cancer per analysis.
Asia-pacific is expected to witness the fastest CAGR of 5.5% over the forecast period of 2025-2032. According to Ascites market analysis, the Asia Pacific region is growing rapidly driven by in the market due to government initiatives. The governments in the region are collaborating with research institutes for the development of effective treatment for ascitic patients. The increasing number of hospitals and specialty clinics is further driving the adoption of advanced ultrasound and paracentesis in the management of ascitic patients. Hence, the ascites market share of Asia Pacific is experiencing rapid growth through rising government initiatives.
According to ascites market analysis, Europe region is experiencing steady growth in the market driven by advanced ambulatory surgical centers. The region is well developed with modern diagnostic technology and skilled oncologists along with digital healthcare infrastructure. Also, the governments in the region are investing in research and development of drug therapy for treatment in ascitic patients. It is further leading to ascites market expansion in the region.
The Middle East and Africa regions are experiencing gradual demand in the market, driven by increasing awareness about rare diseases and improving healthcare industry. Countries such as Dubai, UAE, and South Arica are major contributors in the market where advanced hospitals and government organizations provide access to advanced diagnosis and treatment options for ascitic patients. Further, the cancer centers in the region are offering advanced treatment for liver cancer thereby reducing fluid accumulation in the patients as per analysis.
As per analysis, the market in Latin America is driven by economic developments and partnerships with international health organizations. Countries such as Brazil, Mexico and Argentina are major contributors in the region due to modern healthcare industry. The rise of ambulatory surgical centers has significantly impacted on the availability of advanced diagnosis and treatment options for rare diseases. Additionally, ascitic patients in the region prefer laparoscopic minimal invasive surgery for the treatment due to its fewer side effects.
The ascites industry is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D) and product innovation to hold a strong position in the global ascites market. Key players in industry include-
Report Attributes | Report Details |
Study Timeline | 2019-2032 |
Market Size in 2032 | USD 2,668.24 Million |
CAGR (2025-2032) | 4.0% |
By Ascites Type |
|
By Type |
|
By End-User |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
In 2024, the ascites market is USD 1,954.44 million.
Asia Pacific is the fastest-growing region in the ascites market.
Ascites Type, Type and End-User are covered in the ascites market.
F. Hoffmann-La Roche Ltd. (Switzerland), Sequana Medical NV (Belgium), and BioVie Inc (United States) are some of the major players in the market.